Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

164
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
164
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.5K
Viral Mutations00:36

Viral Mutations

32.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.7K
Causality in Epidemiology01:21

Causality in Epidemiology

595
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
595
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

74
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
74
Viral Recombination00:57

Viral Recombination

23.7K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis.

Clinical & experimental metastasis·2026
Same author

Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis.

Scientific reports·2026
Same author

A model-based approach to study ant energetics from trajectory data.

PNAS nexus·2026
Same author

Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer.

Clinical breast cancer·2026
Same author

Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study.

European urology oncology·2026
Same journal

Anomalous Radiative Transfer in Heterogeneous Media.

Advanced theory and simulations·2025
Same journal

TRACE-Omicron: Policy Counterfactuals to Inform Mitigation of COVID-19 Spread in the United States.

Advanced theory and simulations·2024
Same journal

Rational Design of de novo CCL2 Binding Peptides.

Advanced theory and simulations·2023
Same journal

Computation of the Binding Energies between Human ACE2 and Spike RBDs of the Original Strain, Delta and Omicron Variants of the SARS-CoV-2: A DFT Simulation Approach.

Advanced theory and simulations·2022
Same journal

Predicting the Effects of Waning Vaccine Immunity Against COVID-19 through High-Resolution Agent-Based Modeling.

Advanced theory and simulations·2022
Same journal

Impacts of Export Restrictions on the Global Personal Protective Equipment Trade Network During COVID-19.

Advanced theory and simulations·2022
See all related articles

Related Experiment Video

Updated: Aug 12, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.4K

Exploring a COVID-19 Endemic Scenario: High-Resolution Agent-Based Modeling of Multiple Variants.

Agnieszka Truszkowska1,2,3, Lorenzo Zino4,5, Sachit Butail6

  • 1Center for Urban Science and Progress Tandon School of Engineering New York University 370 Jay Street Brooklyn NY 11201 USA.

Advanced Theory and Simulations
|January 31, 2023
PubMed
Summary
This summary is machine-generated.

New computational models show that highly effective COVID-19 tests and some vaccine protection can contain new variants. However, Omicron

Keywords:
COVID‐19agent‐based modelepidemiologymultiple variantsurban science

More Related Videos

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.3K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Related Experiment Videos

Last Updated: Aug 12, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.4K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.3K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Area of Science:

  • Epidemiology
  • Computational Biology
  • Public Health

Background:

  • The COVID-19 pandemic is complicated by the emergence of new, more infectious, and vaccine-resistant variants.
  • Infrastructural challenges like personnel and test kit shortages worsen infection surges.
  • Existing computational models struggle to simulate the simultaneous spread of multiple SARS-CoV-2 variants.

Purpose of the Study:

  • To establish a high-resolution computational framework for modeling the simultaneous spread of two COVID-19 variants.
  • To assess the impact of new variants on infection dynamics within a representative U.S. town.
  • To evaluate containment strategies for emerging SARS-CoV-2 strains.

Main Methods:

  • Development of a detailed database for a representative U.S. town.
  • Implementation of a high-resolution agent-based model (ABM).
  • Utilizing the Omicron variant as the base for modeling, with flexibility for incorporating new variants.

Main Results:

  • The spread of new COVID-19 variants can be contained with highly efficacious tests and minimal loss of vaccine protection.
  • The Omicron variant's aggressiveness and waning vaccine immunity suggest an endemic phase.
  • Coexistence of multiple SARS-CoV-2 variants is likely in the ongoing endemic phase.

Conclusions:

  • Effective testing and maintained vaccine efficacy are crucial for controlling new COVID-19 variants.
  • The current trajectory indicates an endemic future for COVID-19, characterized by persistent infections and variant co-circulation.
  • Agent-based modeling provides a valuable tool for understanding and predicting the impact of emerging infectious disease variants.